Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Neural Effects in Adolescents with Autism
NCT05096676Completed
- Start
- Aug 2016
- Primary completion
- Oct 2019
- Modality
- Peptides
01
Overview
Randomised, double-blind trial of oxytocin in Autism Spectrum Disorder (ASD) (2 arms). Primary endpoint: Change in social-related neural components (M100, M170, M250). Started Aug 2016; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT05096676.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05096676.